[Myelocytic leukemia: cytogenetic consideration].
D000208:Acute Disease; D000782:Aneuploidy; D001853:Bone Marrow / Q000648:ultrastructure; D001854:Bone Marrow Cells; D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D002869:Chromosome Aberrations; D002904:Chromosomes, Human, 21-22 and Y; D002999:Clone Cells / Q000648:ultrastructure; D004171:Diploidy; D004314:Down Syndrome / Q000235:genetics; D005198:Fanconi Syndrome / Q000150:complications; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000209:etiology / Q000235:genetics*; D008214:Lymphocytes / Q000648:ultrastructure; D008297:Male
D002066:Busulfan